Abcodia

Abcodia is a clinical-stage company dedicated to developing new tests for the early detection of cancer. The company's first product is the ROCA Test® for the early detection of ovarian cancer.Abcodia’s products are based on expertise in measuring and modeling the dynamic changes of clinical variables over time, including test results of serum markers prior to the clinical diagnosis of cancer. The company has exclusive commercial access to a biobank of 200,000 samples donated by more than 200,000 individuals over a 10-year period for research on the early detection and screening of cancer.Abcodia is a privately held company financed by Albion Ventures, Cambridge Innovation Capital, Scottish Equity Partners, and UCL Business. The company is headquartered in the UK.